Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: Insights from saturn

JACC: Cardiovascular Imaging

Volumn 7, Issue 10, 2014, Pages 1013-1022

  Puri, Rishi ^a   Nissen, Steven E ^a   Shao, Mingyuan ^a   Ballantyne, Christie M ^b   Barter, Phillip J ^c   Chapman, M John ^d   Erbel, Raimund ^e   Libby, Peter ^f   Raichlen, Joel S ^g   Uno, Kiyoko ^a   Kataoka, Yu ^h   Nicholls, Stephen J ^a,h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g ASTRAZENECA   (United Kingdom)

^h UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

atherosclerosis; atorvastatin; IVUS; rosuvastatin; statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ADULT; ARTICLE; ATHEROMA; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SEX DIFFERENCE; TREATMENT OUTCOME; AGED; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; MIDDLE AGED;

AGED; C-REACTIVE PROTEIN; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; MIDDLE AGED; PYRIMIDINES; PYRROLES; SEX FACTORS; SULFONAMIDES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84908038000     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.04.019     Document Type: Article

References (35)

1. K.M. Anderson, W.P. Castelli, and D. Levy Cholesterol and mortality. 30 years of follow-up from the Framingham study JAMA 257 1987 2176 2180
2. C. Baigent, L. Blackwell, and J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
3. B. Mihaylova, J. Emberson, and L. Blackwell The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
4. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
5. M. Kendrick Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No. BMJ 334 2007 983
6. S.M. Grundy Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes. BMJ 334 2007 982
7. C. Melloni, J.S. Berger, and T.Y. Wang Representation of women in randomized clinical trials of cardiovascular disease prevention Circ Cardiovasc Qual Outcomes 3 2010 135 142
8. A.L. Blomkalns, A.Y. Chen, and J.S. Hochman Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative J Am Coll Cardiol 45 2005 832 837
9. C. Daly, F. Clemens, and J.L. Lopez Sendon Gender differences in the management and clinical outcome of stable angina Circulation 113 2006 490 498
10. S.E. Nissen, S.J. Nicholls, and I. Sipahi Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
11. S.J. Nicholls, C.M. Ballantyne, and P.J. Barter Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
12. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
13. J.C. LaRosa, S.M. Grundy, and D.D. Waters Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
14. S.J. Nicholls, M. Borgman, and S.E. Nissen Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN) Curr Med Res Opin 27 2011 1119 1129
15. S.J. Nicholls, A. Hsu, and K. Wolski Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407
16. C.N. Bairey Merz, S. Mark, and B.D. Boyan Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies J Womens Health (Larchmt) 19 2010 1059 1072
17. L.J. Shaw, C.N. Bairey Merz, and C.J. Pepine Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies J Am Coll Cardiol 47 2006 S4 S20
18. S. Dey, M.D. Flather, and G. Devlin Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events Heart 95 2009 20 26
19. R. Bugiardini, J.L. Estrada, K. Nikus, A.S. Hall, and O. Manfrini Gender bias in acute coronary syndromes Curr Vasc Pharmacol 8 2010 276 284
20. A. Shehab, B. Al-Dabbagh, and K.F. AlHabib Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2) PLoS One 8 2013 e55508
21. J. Gutierrez, G. Ramirez, T. Rundek, and R.L. Sacco Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis Arch Intern Med 172 2012 909 919
22. W.J. Kostis, J.Q. Cheng, J.M. Dobrzynski, J. Cabrera, and J.B. Kostis Meta-analysis of statin effects in women versus men J Am Coll Cardiol 59 2012 572 582
23. E. Vos, and C.P. Rose Questioning the benefits of statins CMAJ 173 2005 1207 author reply 1210
24. Blumenthal RS, Redberg R. Should healthy people take cholesterol drugs to prevent heart disease? Wall Street Journal [online], January 23 2012. Available at: http://online.wsj.com/article/SB10001424052970203471004577145053566185694.html#U6034616960337PF. Accessed January 23, 2012.
25. S. Mora, R.J. Glynn, J. Hsia, J.G. MacFadyen, J. Genest, and P.M. Ridker Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials Circulation 121 2010 1069 1077
26. R. Puri, S.E. Nissen, and C.M. Ballantyne Factors underlying regression of coronary atheroma with potent statin therapy Eur Heart J 34 2013 1818 1825
27. S.J. Nicholls, K. Wolski, and I. Sipahi Rate of progression of coronary atherosclerotic plaque in women J Am Coll Cardiol 49 2007 1546 1551
28. Q.J. van den Bouwhuijsen, M.W. Vernooij, A. Hofman, G.P. Krestin, A. van der Lugt, and J.C. Witteman Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study Eur Heart J 33 2012 221 229
29. G.W. Stone, A. Maehara, and A.J. Lansky A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
30. J. Ruiz-Garcia, A. Lerman, and G. Weisz Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study EuroIntervention 8 2012 929 938
31. R. Puri, P. Libby, and S.E. Nissen Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN Eur Heart J Cardiovasc Imaging 15 2014 380 388
32. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association J Am Coll Cardiol 58 2011 2432 2446
33. Q.A. Truong, S.A. Murphy, C.H. McCabe, A. Armani, and C.P. Cannon Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22 Circ Cardiovasc Qual Outcomes 4 2011 328 336
34. R. Puri, K. Wolski, and K. Uno Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events J Am Coll Cardiol Intv 6 2013 29 35
35. S.C. Bergheanu, T. Reijmers, and A.H. Zwinderman Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins Curr Med Res Opin 24 2008 2477 2487